Cargando…
Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals
Myasthenia gravis (MG) is a chronic, fluctuating, antibody-mediated autoimmune disorder directed against the post-synaptic neuromuscular junctions of skeletal muscles, resulting in a wide spectrum of manifestations ranging from mild to potentially fatal. Given its unique natural course, designing an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152838/ https://www.ncbi.nlm.nih.gov/pubmed/35639288 http://dx.doi.org/10.1007/s40265-022-01726-y |